Globeflex Capital L P
- SEC CIK
- 0000921531
- Latest filing
- Aug 12, 2026
PBYI holding history
Puma Biotechnology, Inc. in every 13F filed by Globeflex Capital L P, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PBYI overviewAll 13F holders of PBYIFull Q2 2026 holdings
- Shares (Q2 2026)
- 382,807
- Value
- $3.10M
- % of portfolio
- 0.4%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 382,807 | $3.10M | 0.4% | +33,156+9.5% | Added | Holders |
| Q1 2026 | 349,651 | $2.23M | 0.3% | −102,955−22.7% | Reduced | Holders |
| Q4 2025 | 452,606 | $2.69M | 0.4% | 00.0% | Unchanged | Holders |
| Q3 2025 | 452,606 | $2.40M | 0.4% | 00.0% | Unchanged | Holders |
| Q2 2025 | 452,606 | $1.55M | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 452,606 | $1.34M | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 452,606 | $1.38M | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 452,606 | $1.15M | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 452,606 | $1.48M | 0.2% | −39,145−8.0% | Reduced | Holders |
| Q1 2024 | 491,751 | $2.61M | 0.3% | −46,808−8.7% | Reduced | Holders |
| Q4 2023 | 538,559 | $2.33M | 0.2% | 00.0% | Unchanged | Holders |
| Q3 2023 | 538,559 | $1.42M | 0.2% | −22,971−4.1% | Reduced | Holders |
| Q2 2023 | 561,530 | $1.98M | 0.2% | 00.0% | Unchanged | Holders |
| Q1 2023 | 561,530 | $1.74M | 0.2% | 00.0% | Unchanged | Holders |
| Q4 2022 | 561,530 | $2.38M | 0.3% | −9,310−1.6% | Reduced | Holders |
| Q3 2022 | 570,840 | $1.35M | 0.2% | +151,518+36.1% | Added | Holders |
| Q2 2022 | 419,322 | $1.20M | 0.3% | +69,098+19.7% | Added | Holders |
| Q1 2022 | 350,224 | $1.01M | 0.2% | −63,157−15.3% | Reduced | Holders |
| Q4 2021 | 413,381 | $1.26M | 0.3% | −311−0.1% | Reduced | Holders |
| Q3 2021 | 413,692 | $2.90M | 0.6% | −34,009−7.6% | Reduced | Holders |
| Q2 2021 | 447,701 | $4.11M | 0.7% | +19,021+4.4% | Added | Holders |
| Q1 2021 | 428,680 | $4.17M | 0.8% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.